Načítá se...
Combination of Novoseven and Feiba in Hemophiliac Patients with Inhibitors
The aim of this study is to investigate the effective therapeutic combination of recombinant VIIa(Novoseven) and factor eight inhibitor bypass activity(FEIBA) drugs for the bleedings of adult hemophiliac patients with inhibitors.19 bleeding episodes of 5 hemophilia A patients who were using bypassin...
Uloženo v:
| Vydáno v: | Open Med (Wars) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
De Gruyter
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6310920/ https://ncbi.nlm.nih.gov/pubmed/30613789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2018-0090 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|